"I always felt like there was just something wrong with me," Michelle Smith told Newsweek, after years of itchy skin.

The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...

Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospec | Sanofi has reported mixed phase 3 data ...

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...

Winters are known to worsen symptoms of eczema due to dropping temperatures.It is believed that around 8 million people in ...

Millions of Brits with eczema are almost twice as likely to suffer agonising eye and bowel conditions, research suggests.

Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U ...

Corvus Pharma (CRVS) stock surges as the company plans a Phase 2 trial for its lead asset against eczema following ...

We recently published 10 Stocks With Effortless Double-, Triple-Digit Gains. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) was ...

Analyzing patient health care notes recorded during millions of medical appointments at GPs and hospitals across England has ...

Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...

Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...